I used it on my mother's feet (she's 90). She is great for testing anything because she's in an incredible amount of pain and absolutely NOTHING works for her. Two hours after I applied it, she came into my room and said, "I can't believe that cream actually worked. I still don't have any pain in my toes and the bottom of my feet. It worked so well, I forgot about the pain after you put it on..." Needless to say, she looks forward to an application every evening.
In September 2018, following its approval by the FDA for rare types of childhood epilepsy, Epidiolex was rescheduled (by the Drug Enforcement Administration) as a Schedule V drug to allow for its prescription use. This change applies only to FDA-approved products containing no more than 0.1 percent THC. This allows GW Pharmaceuticals to sell Epidiolex, but it does not apply broadly and all other CBD-containing products remain Schedule I drugs. Epidiolex still requires rescheduling in some states before it can be prescribed in those states.
I've been waiting for weeks to receive this topical to see if I finally found a product that works and I'm so happy to say that I did! I've been dealing with knee pain that my doctor has not been able to officially diagnose and treat and it's extremely painful. This is the first product that I've tried that actually relieves most of the pain and pressure so I can continue to workout and stand without being in so much pain. Thank you for creating such an amazing product!
The discussion on the legal status of CBD revolves mainly around the question: is it a medicine or a natural food supplement? The main difference is that medicinal drugs are considered unsafe until proven safe, whereas food supplements are considered safe until proven otherwise. As a result, the central question becomes whether or not CBD is safe for consumers (children, elderly, patients) in large and unregulated quantities. Although there is only limited knowledge about the long-term effects of chronic use, or about drug-drug interactions between CBD and other medications , human studies have indicated that CBD is very well tolerated even up to a daily dose of 1,500 mg . Indeed, a recent World Health Organization (WHO) review concluded that “to date, there is no evidence of recreational use of CBD or any public health-related problems associated with the use of pure CBD” . However, the risks to be assessed about CBD products may not have much to do with the pure compound CBD itself, but more with the unknown composition and quality of the products offered. In particular, we should be looking into the presence of contaminants in these concentrated extracts, and into incorrect or even misleading labels for the cannabinoid content of products.
Cannabidiol is currently a class B1 controlled drug in New Zealand under the Misuse of Drugs Act. It is also a prescription medicine under the Medicines Act. In 2017 the rules were changed so that anyone wanting to use it could go to the Health Ministry for approval. Prior to this, the only way to obtain a prescription was to seek the personal approval of the Minister of Health.